IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2005;46:4092-4096.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.05-0324
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, H.
Right arrow Articles by Yue, B. Y. J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, H.
Right arrow Articles by Yue, B. Y. J. T.

Developmentally Regulated Expression of Sp1 in the Mouse Cornea

Hiroshi Nakamura,1 Jun Ueda,1,2 Joel Sugar,1 and Beatrice Y. J. T. Yue1

1From the Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago College of Medicine, Chicago, Illinois.


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
PURPOSE. To examine the expression of transcription factor Sp1 in the cornea of the mouse eye throughout developmental stages. The environmental effect of light on Sp1 expression was also assessed.

METHODS. C57BL/6 mice were set up for timed mating. Embryos on embryonic day (E)10.5, E12.5, E15.5, and E18.5 and eyes from mice on postnatal day (P)0, P7, P11, P15, P30, and P60 were collected for immunohistochemical staining and in situ hybridization. One group of mice was bred strictly in the dark between E18.5 and P15, and the eyes were collected at P0, P7, P11, and P15 time points.

RESULTS. Sp1 expression was observed in the ectoderm and lens vesicle as early as E10.5. Both Sp1 protein and mRNA were abundant in the corneal basal epithelium and keratocytes until P11. Their levels were markedly reduced at P15, right after eyelid opening, and declined further between P15 and P60. In those mice bred in the dark, Sp1 was evident in the cornea at P0. The Sp1 level gradually increased until P11 and was decreased at P15. This expression pattern was nearly identical in mice bred either in a light/dark cycle or in the dark. The Sp1 level in the central lens epithelium was much lower than that in the cornea from E15.5 to late stages.

CONCLUSIONS. The present study indicates that Sp1 expression is developmentally regulated, providing a basis for further investigations on the regulation of the Sp1 gene during the course of corneal development and in diseases such as keratoconus.

Sp1, one of the first eukaryotic transcription factors identified, was originally cloned as a factor that binds to the SV40 early promoter.1 2 It is the founding member of a growing family of proteins with highly homologous zinc-finger domains close to the C terminus.3 4 5 6 The three zinc fingers bind GC or GT boxes in the promoter or enhancer region7 of many genes. Ubiquitously expressed,8 this nuclear protein has been implicated in the activation or suppression of a large number of genes and is shown to be involved in cellular process such as cell cycle regulation,9 10 11 chromatin remodeling,12 13 prevention of CpG island methylation,14 15 and apoptosis.11 16 17 18 Sp1 knockout mice further revealed that Sp1 is essential for normal mouse embryogenesis. All Sp1–/– mice die at approximately day 11 of gestation.19

Keratoconus is a noninflammatory disease characterized by thinning, scarring, and the eventual protrusion of the central portion of the cornea.20 21 22 23 Research in our laboratory has demonstrated that Sp1 expression is upregulated in the epithelium and stroma of the cornea,24 but not in the conjunctiva of keratoconus patients.25 Immunohistochemical and biochemical studies have shown that the defect of keratoconus may lie in an abnormality in degradation processes.26 27 Degradative enzymes, including cathepsins B and G, are upregulated in keratoconus,28 29 30 and protease inhibitors such as {alpha}1-proteinase inhibitor ({alpha}1-PI) are downregulated.31 32 Our laboratory has identified multiple Sp1 binding sites in the promoter region of the human {alpha}1-PI gene.33 Furthermore, overexpression of Sp1 in cultured human corneal fibroblasts and epithelial cells has been shown to repress the {alpha}1-PI promoter activity33 34 but not the activity of other keratoconus-affected genes. These findings suggest that the Sp1-mediated downregulation of the {alpha}1-PI gene may be a key event leading to the increased degradation and pathologic condition of keratoconus corneas.

In terms of the mechanism by which Sp1 itself is regulated, transcriptional regulation of the human Sp1 has been shown to depend on the relative amount of Sp1, Sp3, E2F, and NF-Y in vivo.35 Gene expression in tissues is presumably influenced by developmental and environmental factors.36 To gain insight into the developmental regulation of Sp1, the present study was undertaken to examine the spatial and temporal expression of Sp1 in the mouse cornea throughout developing stages.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
Mouse Preparation
C57BL/6 mice were raised within the Biological Resources Laboratory of the University of Illinois at Chicago (UIC) with a 14-hour light cycle and a standard chow diet. Mice were handled in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The animal protocol was approved by the UIC animal care committee. For timed pregnancies, the day on which plugs were observed was considered the first day of gestation. Because diurnal variations are known to occur in the expression of transcription factors such as CLOCK and BMAL1,37 all animals were killed between 9 and 11 AM. Embryos or eyes were collected on embryonic day (E)10.5, E12.5, E15.5, and E18.5 and on postnatal day (P)0, P7, P 11, P15, P30, and P60.

To assess the environmental effect on the Sp1 expression in the developing cornea, one group of mice was bred strictly in the dark between E18.5 and P15. Eyes were collected on P0, P7, P11, and P15 and were fixed as described below with minimal exposure to green-free light.

Immunohistochemical Analysis
Embryos or eyes were fixed at 4°C in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 6 hours and were processed for paraffin sections.38 Four series of paraffin sections for each time point were prepared.

For immunohistochemistry, 5-µm–thick paraffin-embedded sections were deparaffinized, rehydrated, and incubated at room temperature with polyclonal rabbit anti-Sp1 (PEP 2) antibody (diluted 1:100; Santa Cruz Biotechnology, Santa Cruz, CA) for 90 minutes. Biotinylated goat anti–rabbit IgG (1:200; Jackson ImmunoResearch Laboratories, West Grove, PA) was used as secondary antibody incubation at room temperature for 45 minutes. The color reaction for anti-Sp1 was carried out (Fast Red TR/Naphthol AS-MX Phosphate; Sigma, St. Louis, MO) for 5 minutes after the sections were incubated with alkaline phosphatase-conjugated Extravidin (1:50; Sigma). After mounting in aqueous mounting fluid, the staining intensity was scored by three masked observers. Minus signs indicated no staining, and plus signs indicated very faint to increasingly intense staining. For each embryonic and postnatal time point, four and three sets of paraffin sections were used to examine the levels of Sp1 in the 14-hour light cycle and in the dark, respectively. Experiments were repeated 3 times.

In Situ Hybridization
Paraffin-embedded sections were deparaffinized and rehydrated. Sections were digested at 37°C with proteinase K (10 µg/µL; Promega) for 12 minutes and postfixed at 4°C with 1% paraformaldehyde in diethyl pyrocarbonate (DEPC)–treated water for 5 minutes. Slides were hybridized at 42°C overnight with digoxigenin-labeled Sp1 cDNA probe (1.5 µg/mL) prepared using a labeling kit (PCR DIG; Roche, Indianapolis, IN). These probes were synthesized from the total RNA isolated from C57BL/6J mouse eyes using target-specific primers (Sp1, 5'-GGCAATAATGGGGGTAGCGG-3' and 5'-CAAGCTGGCAGAACTGATGGC-3'). Tissues were further incubated with alkaline phosphatase-conjugated anti-digoxigenin (Roche), and the color was developed by reaction with NBT/BCIP (Roche). The sections were mounted, and the staining was scored as described. Two sections for each embryonic and postnatal time point were included, and experiments were repeated 3 times.


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
By immunohistochemical staining, the presence of Sp1 was evident in the lens pit (future lens epithelium) as early as E10.5 (Fig. 1 , E10.5). At E12.5 (Fig. 1 , E12.5), Sp1 expression in the nuclei was abundant in the ectoderm (future corneal epithelium) and mesenchyme (future corneal stroma and endothelium). The Sp1 level at E15.5 and E18.5 (Fig. 1 , E15.5 and E18.5) remained relatively high in the corneal epithelium and stroma, and the robust expression in the cornea continued until P11 (Fig. 1 , P11). Notably, the expression of Sp1 in basal corneal epithelial cells and keratocytes was much reduced at P15 (Fig. 1 , P15), right after eyelid opening, which occurred at P13 or P14. The Sp1 level in both types of cells further declined between P15 and P60, whereas a few superficial corneal epithelial cells were found moderately to strongly positive for anti-Sp1 from P30 to P60 (Fig. 1 , P30 and P60). In the corneal endothelium, the Sp1 staining pattern was different from that of corneal epithelial cells and keratocytes. The protein was observed at P0, and the level remained low until P7. It was increased to a moderate level at P11 but was reduced again at P15 and remained low afterward (Fig. 1 , P0-P60).



View larger version (142K):
[in this window]
[in a new window]
  		FIGURE 1. Immunostaining for Sp1 in the developing mouse cornea and lens. Sp1 staining (pink) was observed as early as E10.5 in the lens pit (future lens epithelium). At E12.5, Sp1 expression was abundant in the ectoderm (future corneal epithelium) and mesenchyme (future corneal stroma and endothelium). Moderate to strong nuclear staining in the basal corneal epithelium and stroma was seen between E15.5 and P11. It was dramatically reduced at P15 and then gradually declined with further maturation. A few superficial corneal epithelial cells were highly stained from P30 to P60. The expression in the lens epithelium, by comparison, was low at all stages. A serial section of the E15.5 specimen was incubated with normal rabbit IgG instead of anti-Sp1 as a negative control. Arrow: lens pit at E10.5 and the lens epithelium at subsequent stages; arrowhead: ectoderm at E12.5 and the corneal epithelium at later time points. M, mesenchyme; S, corneal stroma. Bar, 50 µm.

 
Staining of Sp1 in the central lens epithelium was much lower than that in the cornea. The highest level in the lens epithelium was noted at E12.5. After E15.5, Sp1 levels continued to diminish until nearly absent at postnatal stages (Fig. 1 , E10.5-P60).

In situ hybridization experiments detected positive hybridization products for Sp1 transcript in the lens pit at E10.5 (data not shown) and in the ectoderm and mesenchyme at E12.5 (Fig. 2 , E12.5). The Sp1 transcript was also found in the corneal epithelium and stroma at E15.5 (Fig. 2 , E15.5). The high level of Sp1 mRNA in these corneal layers continued until P11 (Fig. 2 , P11). It was then noticeably reduced at P15 in the basal corneal epithelial cells and keratocytes and remained low until P60 (Fig. 2 , P15-P60). In the endothelium, Sp1 mRNA was observed at P7, and the strongest staining was seen at P11. It was diminished to a low level at P60. In the lens epithelium, the transcript of Sp1 was barely detectable throughout the stages between E15.5 and P60 (Fig. 2 , E15.5-P60).



View larger version (131K):
[in this window]
[in a new window]
  		FIGURE 2. In situ hybridization for Sp1 in the developing mouse cornea and lens. Purplish blue hybridization products for Sp1 transcript were detected in the ectoderm and mesenchyme at E12.5. The transcript was also found in the corneal epithelium and stroma from E15.5 until P11. It was then reduced at P15 in the basal corneal epithelial cells and keratocytes and remained weak thereafter until P60. In the lens epithelium, the Sp1 transcript was scanty between E15.5 and P60. A serial section of the E15.5 specimen was incubated with reagent mixture without the cDNA probe as a negative control. Arrow: lens epithelium; arrowhead: ectoderm at E12.5 and corneal epithelium at later time points. M, mesenchyme; S, corneal stroma.

 
Staining intensity for Sp1 in the basal corneal epithelium, stroma, and endothelium and the lens epithelium at each developmental stage point was scored. The range of scores is summarized in Table 1 . Both immunostaining and in situ hybridization showed a declining Sp1 expression pattern.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Immunostaining and In Situ Hybridization Patterns of Sp1

 
In mice bred in the dark, Sp1 immunostaining was evident in basal corneal epithelial cells and keratocytes at P0 (Fig. 3 , P0). The moderate to strong expression continued until P11 (Fig. 3 , P7 and P11). It was, however, found much reduced at P15 (Fig. 3 , P15). This pattern of Sp1 expression was nearly identical with that observed in the mice bred in a 14-hour light cycle, shown in Figure 1 .



View larger version (128K):
[in this window]
[in a new window]
  		FIGURE 3. Immunostaining for Sp1 in mice bred in the dark. In these mice, Sp1 protein expression was evident in basal corneal epithelial cells and keratocytes at P0, P7, and P11. It was found much reduced at P15. This pattern of Sp1 expression was nearly identical with that observed in the mice bred in the 14-hour light cycle shown in Figure 1 . Arrowhead: corneal epithelium. S, corneal stroma. Bar, 50 µm.

 

   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
The present study demonstrates that the expression of transcription factor Sp1 in the mouse cornea is developmentally regulated. Immunohistochemical studies indicated that the Sp1 protein in the cornea, especially in corneal basal epithelial cells and keratocytes, was abundant until P11. It was dramatically decreased at P15 and remained low in the adult mouse cornea except in a few superficial epithelial cells. By contrast, the Sp1 level in the central lens epithelium was very weak from E18.5 to all the late stages. Sp1 might not have as important a role in the late lens differentiation as other transcription factors, such as Krüppel-like factor 6.39 It is of note nonetheless that the Sp1 expression pattern in the lens and the corneal epithelium is different, even though both are derived from the ectoderm between E10.5 and E12.5. These observations are consistent with results from previous developmental8 and Sp1 null mouse19 studies that the expression of Sp1 differs in various cell types during development and that, aside from its general role in the transcription of housekeeping genes, Sp1 has an important regulatory function in development. Also in agreement with previous findings,8 our data show that Sp1 is downregulated in fully differentiated cells, such as corneal epithelial cells and keratocytes, of adult mouse and in the nondividing and essentially quiescent central epithelial cells40 of the lens.

Sp1 in the corneal basal epithelium and keratocytes exhibits a dramatic decrease from P11 to P15 that seems to coincide with eyelid opening. This result suggests that developmental programming or environmental changes caused by eyelid opening, including altered light and increased oxidative stress,36 41 may influence Sp1 expression. To evaluate the effect of light on Sp1 expression, one group of mice was bred in the dark. In these mice, the Sp1 level in the cornea at P15 was still much lower than that at P11. Therefore, we concluded that the altered light might not have had much influence on Sp1 expression during corneal development. Further investigation into the impact of oxidative stress and other factors on the Sp1 expression is merited.

The developmental pattern of Sp1 mRNA transcript in the mouse cornea, as revealed by in situ hybridization, paralleled that of the protein expression of Sp1. Sp1 protein has been shown to be related to a large extent to the mRNA level,8 but there are also other control mechanisms, such as proteasome-dependent degradation.42 43 Our data suggest that Sp1 protein in the mouse cornea is mostly regulated at the transcriptional level.

In the adult mouse cornea (Fig. 1 , P30 and P60), strong Sp1 expression was observed in a few superficial epithelial cells. Epithelial renewal is a constant feature of the corneal epithelium in homeostasis.44 Precisely how cells are lost from the corneal epithelium has not been fully clarified, though Ren and Wilson45 suggest that apoptosis46 is involved. Fas ligand (FasL) is a key physiologic inducer of apoptosis.47 It was reported that FasL mRNA is expressed in primary cultures of human corneal fibroblasts, epithelial cells, and endothelial cells.48 FasL protein was detected in the epithelial and endothelial cells in fresh-frozen human corneas,48 and it was also noted in keratocytes under diseased conditions such as in Fuchs’ corneal dystrophy49 and keratoconus (Nakamura H, et al., unpublished observation, 2003). Recently, evidence has been provided that Sp1 upregulates apoptosis through the promoter region of FasL and caspase 3 in differentiated cells including Sertoli, Jurkat, T, smooth muscle, and PC12 cells.11 16 17 18 50 We thus speculate that Sp1 expression may be related to the apoptotic process in the superficial corneal epithelial cells.

For more quantitative data, we attempted Western blot and relative quantitative RT-PCR analyses at least three times using the developing corneal samples (data not shown). However, the results did not correlate well with those of the immunohistochemical analysis and in situ hybridization. Samples used for quantitative analyses were from full-thickness corneas because it was difficult to dissect each corneal layer separately. It is thus reasoned that the inclusion of corneal endothelial cells and superficial epithelial cells that showed intense Sp1 expression might have presented a complicated scenario. Isolation of single cells from different layers of corneal tissues seems to be necessary, and recently developed techniques such as laser capture microdissection may aid in this effort.

Although the mechanism is unclear, Sp1 has been shown to be upregulated in keratoconus. Results of the present study imply that perhaps in keratoconus, the postdevelopmental program engineered to silence Sp1 is aberrant such that the Sp1 level in the mature cornea remains abnormally high or unsuppressed. The human Sp1 promoter has been cloned and characterized,51 and the 1.6-kb promoter is GC rich. The presence of CpG islands suggests the possibility that epigenetic mechanisms such as DNA methylation52 53 54 and histone acetylation53 55 may be involved in the transcriptional regulation of Sp1.

In summary, we presented herein a dynamic pattern of developmental expression of transcription factor Sp1 in the mouse cornea. The results provide a basis for further investigation into the regulation of the Sp1 gene during corneal development and in diseases such as keratoconus.


   Acknowledgements
 
The authors thank Maria Ramirez, Xiang Shen, and Ruth Zelkha for assistance in immunohistochemical experiments and imaging and Mary Ann Stepp, George Washington University, for pilot studies.


   Footnotes
 
2 Present affiliation: Department of Ophthalmology, Niigata University School of Medicine, Niigata, Japan. Back

Supported by Grants EY03890 (BYJTY) and EY05628 (BYJTY) and by Core Grant EY01792 from the National Institutes of Health, Bethesda, Maryland; and by a Senior Scientific Investigator award from Research to Prevent Blindness, New York, New York.

Submitted for publication March 14, 2005; revised July 5, 2005; accepted September 15, 2005.

Disclosure: H. Nakamura, None; J. Ueda, None; J. Sugar, None; B.Y.J.T. Yue, None

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Corresponding author: Beatrice Y. J. T. Yue, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago College of Medicine, 1855 W. Taylor Street, Chicago, IL 60612; beatyue{at}uic.edu.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Dynan WS, Tjian R. Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell. 1983;32:669–680.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  2. Gidoni D, Dynan WS, Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature. 1984;312:409–413.[CrossRef][Medline][Order article via Infotrieve]
  3. Suske K. The Sp family of transcription factors. Gene. 1999;238:291–300.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  4. Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol. 2002;195:27–38.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  5. Kaczynski J, Cook T, Urrutia R. Sp1 and Krüppel-like transcription factors. Genome Biol. 2003;4:206.[CrossRef][Medline][Order article via Infotrieve]
  6. Li L, He S, Sun M, Davie JR. Gene regulation by Sp1 and Sp3. Biochem Cell Biol. 2004;82:460–471.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  7. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 1987;51:1079–1090.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  8. Saffer JD, Jackson SP, Annarella MB. Developmental expression of Sp1 in the mouse. Mol Cell Biol. 1991;11:2189–2199.[Abstract/Free Full Text]
  9. Karlseder J, Rotheneder H, Wintersberger E. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol. 1996;16:1659–1667.[Abstract/Free Full Text]
  10. Black AR, Jensen D, Lin SY, Azizkhan JC. Growth/cell cycle regulation of Sp1 phosphorylation. J Biol Chem. 1999;274:1207–1215.[Abstract/Free Full Text]
  11. Kavurama MM, Khachigian LM. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4–p21WAF1/Cip1 complex formation. J Biol Chem. 2003;278:32527–32543.
  12. Jongstra J, Reudelhuber TL, Oudet P, et al. Induction of altered chromatin structures by simian virus 40 enhancer and promoter elements. Nature. 1984;307:708–714.[CrossRef][Medline][Order article via Infotrieve]
  13. Ellis J, Tan-Un KC, Harper A, et al. A dominant chromatin-opening activity in 5' hypersensitive site 3 of the human beta-globin locus control region. EMBO J. 1996;15:562–568.[Web of Science][Medline][Order article via Infotrieve]
  14. Brandeis M, Frank D, Keshet I, et al. Sp1 elements protect a CpG island from de novo methylation. Nature. 1994;371:435–438.[CrossRef][Medline][Order article via Infotrieve]
  15. Macleod D, Charlton J, Mullins J, Bird AP. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 1994;8:2282–2292.[Abstract/Free Full Text]
  16. Li-Weber M, Laur O, Hekele A, Coy J, Walczak H, Krammer PH. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur J Immunol. 1998;28:2373–2383.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  17. McClure RF, Heppelmann CJ, Paya CV. Constitutive Fas ligand gene transcription in Sertoli cells is regulated by Sp1. J Biol Chem. 1999;274:7756–7762.[Abstract/Free Full Text]
  18. Kavurma MM, Santiago FS, Bonfoco E, Khachigian LM. Sp1 phosphorylation regulates apoptosis via extracellular FasL-Fas engagement. J Biol Chem. 2001;276:4964–4971.[Abstract/Free Full Text]
  19. Marin M, Karis A, Visser P, Grosveld F, Philipsen S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell. 1997;89:619–628.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  20. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293–322.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  21. Bron AJ. Keratoconus. Cornea. 1988;7:163–169.[Web of Science][Medline][Order article via Infotrieve]
  22. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  23. Bron AJ, Rabinowitz YS. Corneal dystrophies and keratoconus. Curr Opin Ophthalmol. 1996;7:71–82.[Medline][Order article via Infotrieve]
  24. Whitelock RB, Li Y, Zhou L, Sugar J, Yue BYJT. Expression of transcription factors in keratoconus, a cornea-thinning disease. Biochem Biophys Res Commun. 1997;235:253–258.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  25. Maruyama I, Zhou L, Sugar J, Yue BYJT. Normal expression levels of cathepsins, protease inhibitors, and Sp1 in conjunctival tissues from patients with keratoconus. Curr Eye Res. 2000;21:886–890.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  26. Yue BYJT, Sugar J, Benveniste K. Heterogeneity in keratoconus: possible biochemical basis. Proc Soc Exp Biol Med. 1984;175:336–341.[CrossRef][Medline][Order article via Infotrieve]
  27. Yue BYJT, Sugar J, Benveniste K. RNA metabolism in cultures of corneal stromal cells from patients with keratoconus. Proc Soc Exp Biol Med. 1985;178:126–132.[CrossRef][Medline][Order article via Infotrieve]
  28. Sawaguchi S, Yue BYJT, Sugar J, Gilboy JE. Lysosomal enzyme abnormalities in keratoconus. Arch Ophthalmol. 1989;107:1507–1510.[Abstract/Free Full Text]
  29. Sawaguchi S, Twining SS, Yue BYJT, et al. {alpha}2-Macroglobulin levels in normal human and keratoconus corneas. Invest Ophthalmol Vis Sci. 1994;35:4008–4014.[Abstract/Free Full Text]
  30. Zhou L, Sawaguchi S, Twining SS, Sugar J, Feder RS, Yue BYJT. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci. 1998;39:1117–1124.[Abstract/Free Full Text]
  31. Sawaguchi S, Twining SS, Yue BYJT, Wilson PM, Sugar J, Chan SK. {alpha}1- Proteinase inhibitor levels in keratoconus. Exp Eye Res. 1990;50:549–554.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  32. Whitelock RB, Fukuchi T, Zhou L, et al. Cathepsin G, acid phosphatase, and {alpha}1-proteinase inhibitor messenger RNA levels in keratoconus corneas. Invest Ophthalmol Vis Sci. 1997;38:529–534.[Abstract/Free Full Text]
  33. Li Y, Zhou L, Twining SS, Sugar J, Yue BYJT. Involvement of Sp1 elements in the promoter activity of the {alpha}1-proteinase inhibitor gene. J Biol Chem. 1998;273:9959–9965.[Abstract/Free Full Text]
  34. Maruyama Y, Wang X, Li Y, Sugar J, Yue BYJT. Involvement of Sp1 elements in the promoter activity of genes affected in keratoconus. Invest Ophthalmol Vis Sci. 2001;42:1980–1985.[Abstract/Free Full Text]
  35. Nicolas M, Noe V, Ciudad CJ. Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F. Biochem J. 2003;371:265–275.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  36. Piatigorsky J. Enigma of the abundant water-soluble cytoplasmic proteins of the cornea: the "refraction" hypothesis. Cornea. 2001;20:853–858.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  37. Chang DC, Reppert SM. The circadian clocks of mice and men. Neuron. 2001;29:555–558.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  38. Ueda J, Li Y, Goh MS, Maruyama Y, Sugar J, Yue BYJT. Reporter gene construct containing 1.4-kB {alpha}1-proteinase inhibitor promoter confers expression in the cornea of transgenic mice. Anat Rec. 2002;266:5–9.[CrossRef][Medline][Order article via Infotrieve]
  39. Nakamura H, Chiambaretta F, Sugar J, Sapin V, Yue BYJT. Developmentally regulated expression of KLF6 in the mouse cornea and lens. Invest Ophthalmol Vis Sci. 2004;45:4327–4332.[Abstract/Free Full Text]
  40. Bhat SP. The ocular lens epithelium. Biosci Rep. 2001;21:537–563.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  41. Sax CM, Kays WT, Salamon C, Chervenak MM, Xu YS, Piatigorsky J. Transketolase gene expression in the cornea is influenced by environmental factors and developmentally controlled events. Cornea. 2000;19:833–841.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  42. Nishinaka T, Fu YH, Chen LI, Yokoyama K, Chiu R. A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor Sp1. Biochim Biophys Acta. 1997;1351:274–286.[Medline][Order article via Infotrieve]
  43. Su K, Roos MD, Yang X, Han I, Paterson AJ, Kudlow JE. An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J Biol Chem. 1999;274:15194–15202.[Abstract/Free Full Text]
  44. Hanna C, O’Brien JE. Cell production and migration in the epithelial layer of the cornea. Arch Ophthalmol. 1960;64:536–539.
  45. Ren H, Wilson G. Apoptosis in the corneal epithelium. Invest Ophthalmol Vis Sci. 1996;37:1017–1025.[Abstract/Free Full Text]
  46. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456–1462.[Abstract/Free Full Text]
  47. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449–1456.[Abstract/Free Full Text]
  48. Wilson SE, Li Q, Weng J, et al. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci. 1996;37:1582–1592.[Abstract/Free Full Text]
  49. Li QJ, Ashraf MF, Shen DF, et al. The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol. 2001;119:1597–1604.[Abstract/Free Full Text]
  50. Liu W, Wang G, Yakovlev AG. Identification and functional analysis of the rat caspase-3 gene promoter. J Biol Chem. 2002;277:8273–8278.[Abstract/Free Full Text]
  51. Nicolas M, Noe V, Jensen KB, Ciudad CJ. Cloning and characterization of the 5'-flanking region of the human transcription factor Sp1 gene. J Biol Chem. 2001;276:22126–22132.[Abstract/Free Full Text]
  52. Attwood JT, Yung RL, Richardson BC. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci. 2002;59:241–257.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  53. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–463.[CrossRef][Medline][Order article via Infotrieve]
  54. Jiang Y, Bressler J, Beaudet AL. Epigenetics and human disease. Annu Rev Genom Hum Genet. 2004;5:479–510.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  55. Hasan S, Hottiger MO. Histone acetyl transferases: a role in DNA repair and DNA replication. J Mol Med. 2002;80:463–474.[CrossRef][Web of Science][Medline][Order article via Infotrieve]



This article has been cited by other articles:


Home page
 GENES CELLSHome page
X. Shen, J.-S. Park, Y. Qiu, J. Sugar, and B. Y J T Yue
Effects of Sp1 overexpression on cultured human corneal stromal cells
Genes Cells, October 1, 2009; 14(10): 1133 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. K. Swamynathan, J. Davis, and J. Piatigorsky
Identification of Candidate Klf4 Target Genes Reveals the Molecular Basis of the Diverse Regulatory Roles of Klf4 in the Mouse Cornea
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3360 - 3370.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
M. Alberstein, M. Amit, K. Vaknin, A. O'Donnell, C. Farhy, Y. Lerenthal, N. Shomron, O. Shaham, A. D. Sharrocks, R. Ashery-Padan, et al.
Regulation of transcription of the RNA splicing factor hSlu7 by Elk-1 and Sp1 affects alternative splicing
RNA, November 1, 2007; 13(11): 1988 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. K. Swamynathan, J. P. Katz, K. H. Kaestner, R. Ashery-Padan, M. A. Crawford, and J. Piatigorsky
Conditional Deletion of the Mouse Klf4 Gene Results in Corneal Epithelial Fragility, Stromal Edema, and Loss of Conjunctival Goblet Cells
Mol. Cell. Biol., January 1, 2007; 27(1): 182 - 194.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, H.
Right arrow Articles by Yue, B. Y. J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, H.
Right arrow Articles by Yue, B. Y. J. T.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS